effect of gasteroesophageal reflux treatment in cystic fibrosis
Phase 2
Recruiting
- Conditions
- Cystic Fibrosis.Cystic fibrosis
- Registration Number
- IRCT20230312057688N1
- Lead Sponsor
- Ahvaz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Cystic fibrosis patients over 6 years old
Not having advanced respiratory disease
Exclusion Criteria
patients treated with proton pump inhibitors
patients with severe pulmonary disease
non adherence to pulmonary treatments
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Forced vital capacity. Timepoint: At the begining of the study and 2 months after the intervention. Method of measurement: spirometery.;Forced effective volume 1 second. Timepoint: At the begining of the study and 2 months after the intervention. Method of measurement: spirometery.;Forced Effective Volume 25-75. Timepoint: At the begining of the study and 2 months after the intervention. Method of measurement: spirometery.
- Secondary Outcome Measures
Name Time Method